Spain and the AstraZeneca pharmaceutical laboratory hold talks to “ensure” that our country has the treatment against COVID-19 which is still under investigation.
Ricardo R. Suárez, director of AstraZeneca Spain agreed today at the event ‘Solidarity vaccination ‘ with the president Pedro Sanchez“Today we can say that we are already in a very advanced phase with our treatment to effectively confront the control of the coronavirus, especially in people with compromised immune systems that do not respond to vaccines. We hope to make it available to the population shortly. you need it “he said on the spot.
The treatment in question is a cocktail of two monoclonal antibodies named AZD7442, and that it has shown that it reduces up to 88% the cases of severe COVID-19 or death in these patients and up to 83% the risk of developing symptomatic COVID over six months.
The head of the pharmaceutical laboratory has congratulated the Executive for his “enormous effort and inestimable contribution” to stop the pandemic. “The work they have done in Spain has made us one of the best countries in the world in controlling the pandemic”, he assured before specifically citing the work carried out with the vaccination plan and the use of masks.
Suárez stressed that his company continues to work to achieve global immunization goals and to make solutions that go beyond vaccination available to the authorities. Specifically, he stated that his treatment to facilitate protection against the coronavirus is already in a very advanced stage, especially in people with immune systems that do not respond to the vaccine.
The AstraZeneca representative also praised the solidarity shown by Spain so that the vaccine has been distributed in countries that need it most.
–
